Catherine Cusack Buys 1,000 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Free Report) Director Catherine Cusack bought 1,000 shares of the company's stock in a transaction dated Friday, February 21st. The stock was bought at an average price of $16.43 per share, for a total transaction of $16,430.00. Following the acquisition, the director now directly owns 59,083 shares of the company's stock, valued at approximately $970,733.69. This represents a 1.72 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Catherine Cusack also recently made the following trade(s):

• On Monday, February 24th, Catherine Cusack bought 1,500 shares of Sabra Health Care REIT stock. The stock was bought at an average price of $15.92 per share, for a total transaction of $23,880.00.

Sabra Health Care REIT Stock Performance

Sabra Health Care REIT stock traded up $0.16 during mid-day trading on Friday, reaching $16.61. 2,969,923 shares of the company's stock were exchanged, compared to its average volume of 2,086,993. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88. The business's fifty day simple moving average is $16.77 and its 200 day simple moving average is $17.61. Sabra Health Care REIT, Inc. has a one year low of $13.31 and a one year high of $20.03. The firm has a market capitalization of $3.95 billion, a PE ratio of 31.34, a P/E/G ratio of 1.97 and a beta of 1.25.

Remove Ads

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The business had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. On average, sell-side analysts expect that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 7.22%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT's dividend payout ratio is currently 226.42%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 target price on the stock in a report on Tuesday, January 7th. Truist Financial lowered Sabra Health Care REIT from a "buy" rating to a "hold" rating and dropped their price target for the stock from $18.00 to $17.00 in a report on Friday, January 17th. Citizens Jmp upgraded Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 7th. Finally, Mizuho reiterated a "neutral" rating and set a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Sabra Health Care REIT has a consensus rating of "Moderate Buy" and a consensus price target of $19.17.

Institutional Trading of Sabra Health Care REIT

A number of large investors have recently bought and sold shares of the company. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Sabra Health Care REIT in the fourth quarter worth $14,241,000. Jefferies Financial Group Inc. purchased a new position in shares of Sabra Health Care REIT in the fourth quarter valued at $348,000. Mackenzie Financial Corp grew its position in shares of Sabra Health Care REIT by 22.1% in the fourth quarter. Mackenzie Financial Corp now owns 289,870 shares of the real estate investment trust's stock valued at $5,021,000 after purchasing an additional 52,441 shares in the last quarter. GF Fund Management CO. LTD. purchased a new position in shares of Sabra Health Care REIT in the fourth quarter valued at $74,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Sabra Health Care REIT by 2.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,444,703 shares of the real estate investment trust's stock valued at $25,022,000 after purchasing an additional 40,127 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.